Revolution Medicines, Inc. RVMD Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s operating income?
- Revolution Medicines, Inc. (RVMD) reported operating income of -$445.22M in Q1 2026.
- How has Revolution Medicines, Inc.'s operating income changed year-over-year?
- Revolution Medicines, Inc.'s operating income decreased by 84.9% year-over-year, from -$240.76M to -$445.22M.
- What is the long-term trend for Revolution Medicines, Inc.'s operating income?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s operating income has grown at a 58.4% compound annual growth rate (CAGR), from -$188.01M to -$1.18B.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.